Clinical Trial Update: Early Stage Follicular LymphOma and RadioTherapy PLUS Anti-CD20 Antibody [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating radiotherapy plus an anti-CD20 antibody for early-stage follicular lymphoma (WHO grade 1/2 or 3a). The study is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Anti-CD20 antibody

Snippet

Sponsor: Heidelberg University | Conditions: Early Stage Follicular Lymphoma WHO Grade 1/2 or 3a | Phase 3 | Status: RECRUITING